|
|
||||||||
1 Department of Medicine and 2 Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina and Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina 29425
Vascular smooth muscle cell (VSMC) proliferation is a prominent
feature of the atherosclerotic process occurring after endothelial injury. A vascular wall kallikrein-kinin system has been described. The
contribution of this system to vascular disease is undefined. In the
present study we characterized the signal transduction pathway leading
to mitogen-activated protein kinase (MAPK) activation in response to
bradykinin (BK) in VSMC. Addition of
10
10-10
7
M BK to VSMC resulted in a rapid and concentration-dependent increase
in tyrosine phosphorylation of several 144- to 40-kDa proteins. This
effect of BK was abolished by the
B2-kinin receptor antagonist
HOE-140, but not by the B1-kinin
receptor antagonist des-Arg9-Leu8-BK.
Immunoprecipitation with anti-phosphotyrosine antibodies followed by
immunoblot revealed that
10
9 M BK induced tyrosine
phosphorylation of focal adhesion kinase (p125FAK). BK
(10
8 M) promoted the
association of p60src with the
adapter protein growth factor receptor binding protein-2 and also
induced a significant increase in MAPK activity. Pertussis and cholera
toxins did not inhibit BK-induced MAPK tyrosine phosphorylation. Protein kinase C downregulation by phorbol 12-myristate 13-acetate and/or inhibitors to protein kinase C,
p60src kinase, and MAPK kinase
inhibited BK-induced MAPK tyrosine phosphorylation. These findings
provide evidence that activation of the
B2-kinin receptor in VSMC leads to
generation of multiple second messengers that converge to activate
MAPK. The activation of this crucial kinase by BK provides a strong
rationale to investigate the mitogenic actions of BK on VSMC
proliferation in disease states of vascular injury.
B2-kinin receptors; G protein receptors; tyrosine phosphorylation; signal transduction; mitogen-ativated protein kinase
This article has been cited by other articles:
![]() |
J. A. Rodriguez, P. De la Cerda, E. Collyer, V. Decap, C. P. Vio, and V. Velarde Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H30 - H36. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Fernando, L. P. Fernando, Y. Fukuda, and A. P. Kaplan Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H251 - H257. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tan, B. Wang, J.-S. Keum, and A. A. Jaffa Mechanisms through which bradykinin promotes glomerular injury in diabetes Am J Physiol Renal Physiol, March 1, 2005; 288(3): F483 - F492. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tan, F. N. Hutchison, and A. A. Jaffa Mechanisms of angiotensin II-induced expression of B2 kinin receptors Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H926 - H932. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. Mukhin, E. A. Garnovsky, M. E. Ullian, and M. N. Garnovskaya Bradykinin B2 Receptor Activates Extracellular Signal-Regulated Protein Kinase in mIMCD-3 Cells via Epidermal Growth Factor Receptor Transactivation J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 968 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cellier, M. Mage, J. Duchene, C. Pecher, R. Couture, J.-L. Bascands, and J.-P. Girolami Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F282 - F292. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lacza, M. Puskar, B. Kis, J. V. Perciaccante, A. W. Miller, and D. W. Busija Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H406 - H411. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yau, D. P. Wilson, J. P. Werner, and P. Zahradka Bradykinin receptor antagonists attenuate neointimal proliferation postangioplasty Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1648 - H1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Velarde, A. J. Jenkins, J. Christopher, T. J. Lyons, and A. A. Jaffa Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells J Appl Physiol, September 1, 2001; 91(3): 1412 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Christopher, V. Velarde, D. Zhang, D. Mayfield, R. K. Mayfield, and A. A. Jaffa Regulation of B2-kinin receptors by glucose in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1537 - H1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, A. Duzgun, B. E. Sumpio, and M. D. Basson Integrin and FAK-mediated MAPK activation is required for cyclic strain mitogenic effects in Caco-2 cells Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G75 - G87. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Douillet, V. Velarde, J. T. Christopher, R. K. Mayfield, M. E. Trojanowska, and A. A. Jaffa Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2829 - H2837. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |